NCT00311870View on ClinicalTrials.gov

Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 1993

Study Completion Date

April 30, 1999

Conditions
Diabetic Nephropathy
Interventions
DRUG

nisoldipine

DRUG

lisinopril

Trial Locations (1)

DK-2820

Steno Diabetes Center, Gentofte Municipality

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Steno Diabetes Center Copenhagen

OTHER